|
|
|
|
 |
| March 1, 2012 | ISSUE NUMBER 240 VOL 8 |
|
Operations
Get Ready for Profound Changes in the
Outsourcing Landscape
While the adoption of integrated and more strategic outsourcing relationships has increased substantially this past year, it has left the outsourcing landscape misshapen and unstable. At the same time, the implementation of integrated relationships during the past two years has been suboptimal prompting many sponsors to modify their governance practices and to rein in their collaborative control. ...Read More
Advertisement
CBI's Bio/Pharma Regulatory Policy Exchange
May 7-8, 2012
Washington, D.C.
Prepare for a new wave of legislative and regulatory policies that will shape the life sciences industry for years to come.
Learn best practices on how the shifting regulatory and policy landscape will affect the biopharma industry going forward with Bayer HealthCare Pharmaceuticals, Bristol Myers Squibb, Eisai, Eli Lilly and Company, EMD Serono, Merck, Novartis and Shire Pharmaceuticals!
Register by March 10th at  www.cbinet.com/policyexchange and save $300 with priority code: QSS925. |
Partnerships
Spotlight on Rare Diseases
Patients, policymakers, and pharmaceutical companies are uniting around rare diseases on the rarest of calendar days, presaging a leap forward in health outcomes and business opportunities. Both the NIH and the FDA are serving as venues for events on Feb. 29 and March 1, respectively, under the banner of solidarity. ...Read More
Marketing
Publicis Expanding into China with Agency Purchase
The Chinese healthcare market is one of the fastest-growing in the world. And as such Publicis Healthcare has acquired U-Link Business Solutions, continuing the company's market penetration in the Asian market and abroad. ...Read More
Technology
Combating Opioid Abuse with Science
So far, the creative approaches industry has taken to develop tamper-resistant and abuse-deterrent opioid drugs have been largely matched by the ingenuity of those users who manage to tamper with and abuse those same formulations. But a new approach to attack recreational abuse of drugs is being put into use by Pfizer and Endo Pharmaceuticals. Will these new measures see results? ...Read More
Advertisement
CBI's 4th Annual Summit on Clinical Trial Investigator Portals
May 15-16, 2012 * Philadelphia, PA
Provide High-Quality Data to Study Teams for Real-Time Reporting
Learn best practices in utilizing clinical portals for efficient study start-up reducing trial costs workload of clinical investigator sites with Merck & Co., Inc., Quintiles, GlaxoSmithKline, and more!!! Register by May 15, 2012 at  www.cbinet.com/portals and save $300 with priority code: GMA284. |
Leadership
Pharma Facing Talent Crunch
A recent poll by PricewaterhouseCoopers states that 51 percent of pharma CEOs feel it has become more difficult to hire workers within the industry, outweighing their counterparts in many other large industries, including automotive, insurance, and technology. The implications of this 'talent crunch' are grave, as it foretells an impact on profitability. ...Read More
Advertisement
Live Webcast: Utilization of Rasch Measurement Models for Accessing Validity
March 14, 2012 at 10:30 AM Eastern Daylight Time
 http://www.pharmexec.com/rasch
|
|
|
|
 // Permeon Biologics (Cambridge, MA) appointed Katherine S. Bowdish, PhD, as President and Chief Scientific Officer.
// Dawn L. Gabriel, PhD, was named Director of Quality and Compliance at QPharma (Morristown, NJ). Gabriel previously held similar positions at J&J and Pfizer. // Cynthia Clayton was promoted to Vice President of Investor Relations and Corporate Communications at Alnylam Pharmaceuticals (Cambridge, MA).
|
 |
| // Ogilvy CommonHealth Worldwide (Parsippany, NJ) elevated Nancy Iler Sladicka, PhD, to the position of Executive Vice President, Account Management. |
|
|
|
|
|
|
 |
|
|
|
|
 |
|
 |
 |
|
 |
What do you think the pharma marketing landscape of 2017 will look like?
|
|
|
|
|
You
are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.
To
ensure delivery to your Inbox, please add us to your
address book. If you need help doing this, click
here.
Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.
|
|
